{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0069-1520",
      "marketing_end_date": "20271031",
      "generic_name": "amlodipine besylate",
      "labeler_name": "PFIZER LABORATORIES DIV PFIZER INC",
      "brand_name": "Norvasc",
      "active_ingredients": [
        {
          "name": "AMLODIPINE BESYLATE",
          "strength": "2.5 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0069-1520-68",
          "description": "90 TABLET in 1 BOTTLE (0069-1520-68)",
          "marketing_start_date": "19920731",
          "marketing_end_date": "20271031",
          "sample": false
        }
      ],
      "openfda": {
        "manufacturer_name": [
          "PFIZER LABORATORIES DIV PFIZER INC"
        ],
        "rxcui": [
          "197361",
          "212542",
          "212549",
          "212575",
          "308135",
          "308136"
        ],
        "spl_set_id": [
          "abd6a2ca-40c2-485c-bc53-db1c652505ed"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "864V2Q084H"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET",
      "spl_id": "3714a872-b6c6-4d74-88d2-add8a895e311",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "19920731",
      "product_id": "0069-1520_3714a872-b6c6-4d74-88d2-add8a895e311",
      "application_number": "NDA019787",
      "brand_name_base": "Norvasc",
      "pharm_class": [
        "Calcium Channel Antagonists [MoA]",
        "Calcium Channel Blocker [EPC]",
        "Cytochrome P450 3A Inhibitors [MoA]",
        "Dihydropyridine Calcium Channel Blocker [EPC]",
        "Dihydropyridines [CS]"
      ]
    }
  ]
}